| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of 1 Pathology and 3 Pharmacology, Cardiovascular Research Institute Maastricht, University of Maastricht, 6200 MD Maastricht, The Netherlands; and Departments of 2 Cardiothoracic Surgery and 4 Cardiology, Medical University of South Carolina, Charleston, South Carolina 29425
 |
ABSTRACT |
|---|
 TOP
 ABSTRACT
 INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Recent studies have been directed at
modulating the heart failure process through inhibition of activated
matrix metalloproteinases (MMPs). We hypothesized that a loss of MMP
inhibitory control by tissue inhibitor of MMP (TIMP)-1 deficiency
alters the course of postinfarction chamber remodeling and induced
chronic myocardial infarction (MI) in wild-type (WT) and
TIMP-1
/ mice. Left ventricular (LV) pressure-volume
loops obtained from WT and TIMP-1/ mice demonstrated
that LV end-diastolic volume [52 ± 4 (WT) vs. 71 ± 6 (TIMP-1/) µl] and LV end-diastolic pressure
[9.0 ± 1.2 (WT) vs. 12.7 ± 1.4 (TIMP-1/)
mmHg] were significantly increased in the TIMP-1/ mice
2 wk after MI. LV contractility was reduced to a similar degree in the
WT and TIMP-1/ groups after MI, as indicated by a
significant fall in the LV end-systolic pressure-volume relationship.
Ventricular weight and cross-sectional areas of LV myocytes were
significantly increased in TIMP-1/ mice, indicating
that the hypertrophic response was more pronounced. The observed
significant loss of fibrillar collagen in the TIMP-1/
controls may have been an important contributory factor for the observed LV alterations in the TIMP-1/ mice after MI.
These findings demonstrate that TIMP-1 deficiency amplifies adverse LV
remodeling after MI in mice and emphasizes the importance of local
endogenous control of cardiac MMP activity by TIMP-1.
myocardial remodeling; pressure-volume loops
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
MATRIX METALLOPROTEINASES (MMPs) are a fundamental proteolytic system responsible for extracellular matrix protein degradation within the myocardium. Under ambient conditions, the myocardial MMPs largely reside in their latent form, whereas after a pathological stimulus the pool of latent MMPs becomes activated, as has been demonstrated for human, rat, and porcine myocardium (3, 6, 33, 34). Prevention of the breakdown of the myocardial extracellular matrix with pharmacological broad-spectrum MMP inhibitors in animal models of cardiomyopathy and myocardial infarction (MI) has demonstrated effects on the left ventricular (LV) architectural remodeling process (4, 20, 27, 32). An important endogenous regulator of overall MMP activity are the tissue inhibitors of MMPs (TIMPs) (18, 19). Normally, the TIMPs are in delicate balance with the MMPs and matrix is digested in a highly regulated fashion. A loss of TIMP-mediated inhibitory control has also been reported to occur in several cardiac pathologies (1, 25). For example, in end-stage cardiomyopathic disease in humans, increased MMP activity is paralleled by decreased TIMP-1, -3, and -4 expression (18). In a preliminary report, it was demonstrated that in TIMP-1-null mice, LV chamber enlargement occurred as a function of age, suggesting that constitutive expression of TIMP-1 is necessary for the maintenance of LV myocardial geometry (29). This study tested the hypothesis that TIMP-1 deficiency would modify the LV chamber and myocardial matrix remodeling after MI compared with age-matched wild-type (WT) mice, despite identical MI size.
| |
METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Experimental animals.
The mice used in these studies were adult inbred 129 Sv mice from which
a stable line of TIMP-1-deficient (TIMP-1/) mice was
created through the use of a replacement vector carrying a stop
codon-containing oligonucleotide and the neo resistance cassette with
the 5' end of the TIMP-1 coding frame (23, 29). The
original breeding pairs used to develop the mice for this study were a
kind gift from Dr. Paul J. Soloway (Roswell Park Cancer Institute,
Buffalo, NY). Tail clips and a PCR protocol were used to
confirm the genotype. All studies were done on age-matched mice (2 mo
of age), and the groups were balanced with respect to gender. MI was
induced surgically by chronic ligation of the coronary artery in
TIMP-1/ mice (n = 29) and age-matched
littermates (n = 33) according to recently described
methods (21). Nonoperated TIMP-1/ mice
(n = 15) and littermates (n = 12)
served as controls. Terminal studies, including echocardiography, LV
conductance volumetry, morphometry, and histology were performed 14 days after MI, as described below. All animals were treated and cared
for in accordance with the National Institutes of Health
Guidelines for the Care and Use of Laboratory Animals
(National Research Council, Washington, DC, 1996).
Echocardiographic measurements. Echocardiography was performed before MI and 2 wk after MI. Mice were sedated (40 mg/kg ketamine and 2 mg/kg xylazine) and placed in a recumbent position on a warming blanket to maintain ambient body temperature. Heart rate was determined from a surface ECG. From a transthoracic approach described previously (9, 29, 31), two-dimensional targeted echocardiographic recordings were obtained with an optimized 15-mHz transducer (15-6L UltraBand; Agilent Technologies, Abbyville, SC) integrated with a digital imaging system (Sonos 5500 Ultraharmonic Imaging System; Agilent Technologies). The two-dimensional parasternal long-axis view of the LV was recorded to precisely define the LV long axis and papillary muscles. The LV endocardial border was manually defined and LV areas at end diastole were computed by planimetry.
LV conductance volumetry.
A 1.1-mm steel endotracheal tube was placed, and the anesthesized mice
were mechanically ventilated (MiniVent 845; Hugo Sachs/Harvard Apparatus, March-Hugstetten, Germany). The mice were positioned on a
feedback temperature-controlled operating table (Vestavia Scientific,
Birmingham, AL). Under microscopic guidance (Zeiss OPMI), the right
carotid artery was exposed. A precalibrated four-electrode pressure
sensor catheter (1.4-Fr, SPR-839; Millar Instruments, Houston, TX) was
positioned in the LV. The catheter was interfaced to a
pressure-conductance unit (ARIA, MPCU-200; Millar Instruments), in
which electrical excitation was performed under digital control (DAQ,
PV Analysis Software; Millar Instruments). The continuous digital
pressure and conductance signals were integrated with an ECG signal
(PowerLab; AD Instruments) and displayed in real time with a
dual-display heads-up flat screen (Sony Electronics). This allowed for
optimal placement of the LV catheter with respect to the LV conductance
signal. The LV conductance signal was converted to a LV volume with an
algorithm described previously (8, 10, 11, 15, 36). One of
the important factors in this algorithm is the determination of a
parallel conductance volume coefficient (Vp)
(8). In the present study, Vp was computed by
using an isotonic saline injection in age-matched WT mice
(n = 3). Briefly, a 5-µl bolus of 15% hypertonic
saline was injected into the external jugular vein and the LV
pressure-conductance signals were continuously acquired. The saline
bolus caused a significant LV volume shift without a marked change in
LV systolic pressure (Fig.
1A). The isochronal LV
systolic and diastolic volumes were plotted along with the line of
identity (Fig. 1B). From the intersection of these two
lines, a mean value of 26 µl was computed for Vp. This factor was used in the software algorithms (PVAN; Millar Instruments) to compute absolute LV volumes. This saline calibration was
repeated on a weekly basis in both WT and TIMP-1/ mice
to ensure that the computed Vp remained within 10% of
predicted values.
|
Immunohistochemistry and morphometry.
At completion of the hemodynamic studies, 0.5 ml of 0.1 mM cadmium
chloride were injected into the LV to arrest the hearts in diastole.
After perfusion with PBS, hearts were excised, weighed, routinely
processed, and imbedded in paraffin. Infarct size, LV diameter,
thickness of the infarcted wall, and collagen deposition were studied 2 wk after surgery in the TIMP-1/ and WT groups with a
computerized morphometry system (Quantimet 570; Leica, Cambridge, UK)
on AZAN- or Sirius red-stained sections (21). Myocyte
cross-sectional area was determined on hematoxylin and eosin-stained
slides with computer-assisted methods described previously
(33). Immunohistochemistry was performed to quantify macrophages (moma-2 monoclonal antibody on cryostat sections; Ref.
17), endothelial cells (anti-thrombomodulin polyclonal antibody; kindly provided by Dr. Peter Carmeliet, Center for Transgene Technology and Gene Therapy, Leuven, Belgium), T cells (anti CD-3; DAKO), smooth muscle cells, and myofibroblasts (mouse anti-human 
-smooth muscle actin; DAKO). Cell numbers were counted per
0.1-mm2 infarcted area by light microscopy at ×40
magnification with a grid.
Statistics.
Data are expressed as means ± SE. Indexes of function and
geometry were compared in controls and at 2 wk after MI in
TIMP-1/ and WT groups with ANOVA, with post hoc mean
separation performed by Bonferroni bounds. Means between groups were
compared with the use of the Mann-Whitney U-test. A value of
P < 0.05 was considered statistically significant.
| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Overall survival after MI surgery was comparable between WT and
TIMP-1/ mice; however, it may be notable that those
TIMP-1/ mice that did die died earlier after MI surgery
than the WT mice. Of the 33 WT and 29 TIMP-1/ mice that
underwent MI surgery, 3 WT (10%) and 8 TIMP-1/ (27%)
mice did not recover from their anesthesia after surgery. In the WT
group, eight additional animals died between days 2 and
10 because of LV rupture (n = 3) or acute
heart failure (n = 5), as judged by postmortem findings
(large infarct, cardiac dilatation, pleural effusion, and severe lung
congestion). In the TIMP-1/ group, no animals were lost
after the first day after surgery. The MI sizes determined by
quantitative morphometric planimetry were identical between the WT and
TIMP-1/ mice. [MI size: 42 ± 3% (WT) vs.
42 ± 3% (TIMP-1/) of the LV circumference].
LV geometry and function.
Long-axis LV echocardiography indicated that LV dilatation was
significantly increased in the TIMP-1/ group in
response to MI, and representative echocardiograms are shown in Fig.
2A. The absolute values for LV
end-diastolic area (LVEDA) were obtained from echocardiograms from WT
and TIMP-1/ mice before and 2 wk after MI. In WT mice,
LVEDA was 140 ± 6 × 103 cm2 and
increased to 176 ± 8 × 103 cm2 in
response to MI (P < 0.05). In the
TIMP-1/ mice, LVEDA was 163 ± 4 × 103 cm2 and significantly increased to
201 ± 5 × 103 cm2 after MI. Both
LVEDA values were significantly elevated in TIMP-1/
groups compared with the corresponding WT groups (both
P < 0.05; n = 11-15 per group).
|
/ mice. At 2 wk after MI, definable changes in
the P-V loops were observed in both WT and TIMP-1/ mice
(Fig. 2B). As can be seen from Fig. 2, a parallel rightward shift of the P-V loop occurred after MI in both WT and
TIMP-1/ mice; however, in the TIMP-1/
mice, this rightward shift was greater. LV end-diastolic volume increased after MI in both groups of mice but was higher in the TIMP-1/ mice compared with the WT mice (Fig.
2C). In addition, LV end-diastolic pressure increased
significantly in the TIMP-1/ mice at 2 wk after MI
compared with age-matched controls or with WT post-MI values (Fig. 2,
B and D). Other hemodynamic parameters are
summarized in Table 1. Under control
conditions, ambient mean arterial pressure and LV peak pressure were
slightly but significantly higher in the TIMP-1/ mice
compared with the WT mice. Although LV architectural remodeling occurred in both WT and TIMP-1/ mice after MI, LV
ejection fraction was unchanged from respective control values. LV
dP/dtmax appeared higher in the control
TIMP-1/ group but decreased after MI. The time constant
of isovolumic relaxation (
) was significantly prolonged in the
TIMP-1/ mice after MI and was not significantly
affected in the WT group.
|
/ mice. LV radial systolic
stress at the septum was similar to posterior free wall values in
control WT and TIMP-1
/ mice (207 ± 48 and 234 ± 28 g/cm2). After MI, LV radial systolic stress at the
posterior free wall increased by over sixfold in both WT and
TIMP-1/ mice and remained unchanged at the septum from
control values in both WT and TIMP-1/ groups (Fig.
3). Thus the increased LV dilatation in
the TIMP-1/ mice after MI was not translated into
increased radial wall stress because of the parallel increase in wall
thickness (i.e., mass).
|
/
control mice (0.032 ± 0.009 and 0.030 ± 0.007 dyn · cm · mg · mmHg1,
respectively; P = 0.83). After MI, the ESPVR
significantly fell to a similar degree in both WT and
TIMP-1/ mice compared with reference controls
(0.016 ± 0.004 and 0.014 ± 0.005 dyn · cm · mg · mmHg1,
respectively; P < 0.05). Thus, despite a preservation
of steady-state LV ejection fraction, LV contractility was
significantly reduced in both WT and TIMP-1/ groups
after MI.
LV myocardial morphometry.
Ventricular mass was significantly larger in the
TIMP-1/ mice compared with the WT mice in both control
and MI animals. The absolute increase in ventricular mass in response
to MI was higher in the TIMP-1/ group, indicating that
the hypertrophic response was more pronounced in
TIMP-1/ than in WT mice (Fig.
4A). Cross-sectional areas of
LV myocytes were measured in a circumferential orientation in both WT
and TIMP-1/ mice and also revealed an increased
hypertrophic response after MI in the TIMP-1/ group
(Fig. 4B).
|
/ mice. With Sirius red staining, the
percentage of the myocardial section occupied by fibrillar collagen was
computed. Extensive collagen deposition was found in the center of the
infarcts, with no differences observed between TIMP-1/
and WT mice. However, in the septum of TIMP-1/ control
animals, we found significantly lower collagen percentages than in WT
controls, indicating that there was a difference in structural
composition of the hearts at the starting point of the experiment.
These reduced collagen levels, together with the observed increase in
infarct length in the TIMP-1/ infarcts (Table 2),
indicate that the remodeling of the infarct region is altered in the
TIMP-1/ mice.
|
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Although alterations in MMP and TIMPs have been identified in
end-stage human heart failure, it has remained unclear whether interruption in the balance between MMPs and TIMPs within the myocardium can directly influence the LV architectural remodeling process after specific pathological stimuli such as MI. The present study demonstrated that a loss of function of TIMP-1 in mice caused significant alterations in LV geometry and function with respect to the
post-MI remodeling process. Specifically, the present study demonstrated that in TIMP-1/ mice, a greater degree of
LV dilation occurred, which was accompanied by a greater hypertrophic
response, increased LV filling pressures, and abnormalities in active
myocardial relaxation.
The majority of past studies that have examined the LV architectural
remodeling process in mice after MI have used transthoracic echocardiography (13, 30). The present study employed this technique and demonstrated that significant LV dilation occurred in
mice after induction of an MI, and the degree of LV dilation that
occurred in the WT mice is consistent with past reports (21, 27). In age-matched TIMP-1/ mice, LV
echocardiographic dimensions were larger than in WT mice, which was
expected from past observations from this laboratory (29).
However, it is difficult to assess absolute LV volumes from
echocardiographic measurements, particularly after MI. Accordingly, the
present study used conductance volumetry to more carefully assess
indexes of LV geometry and function in mice after MI. As expected, LV
volumes were significantly greater in mice after MI in both WT and
TIMP-1/ groups but were disproportionately higher in
TIMP-1/ mice after MI. Despite the significant LV
chamber remodeling that occurred in both WT and TIMP-1/
mice, LV ejection fraction was preserved compared with referenced control values. The present studies were performed at 14 days after MI,
and therefore it remains to be established whether a longer time
interval after MI would have resulted in the development of decreased
LV ejection fraction. However, results from the present study did
demonstrate abnormalities in underlying LV contractile function, which
would suggest that the development to overt LV failure would be likely
with longer followup periods. Specifically, a significant fall in LV
ESPVR occurred in both WT and TIMP-1/ mice after MI.
Whether the significant LV chamber remodeling that occurred in the
TIMP-1/ mice after MI coupled with the diminished
contractile function would accelerate the progression to LV pump
failure remains to be established and warrants further study.
In the present study, a loss of myocardial matrix integrity may have directly affected myocardial contractile performance. Specifically, the maintenance of myocardial fiber alignment and geometry within the LV free wall is determined, at least in part, by the myocyte-integrin-matrix interface (28). The architecture of the myocardial collagen matrix with respect to cardiac muscle alignment was described in early electron microscopy studies (2, 26). In addition, realignment of cardiac muscle fibers was reported previously to occur in rodent models of MI (24). Thus defects in the myocyte-matrix relationship within the post-MI myocardium could significantly influence the transduction of myocyte shortening into muscle fiber shortening.
There are several possible mechanisms for the relatively preserved LV
ejection fractions in the current mouse model. First, in this 129 Sv
mouse strain, the development of overt LV pump failure may take longer
to develop than those reported previously. Second, LV ejection fraction
is highly dependent on loading conditions. The present study
demonstrated that an index of LV systolic function was significantly
reduced in both WT and TIMP-1/ MI mice. Thus a defect
in LV function was demonstrated in the present study. Third, the
present study cannot discount whether the MI or catheterization
procedure superimposed on the MI caused mitral regurgitation. This low
impedance outlet would cause a pseudonormalization of LV ejection
fraction. This possibility is supported by the fact that the LV ESPVR
was reduced in the MI mice. Thus future studies that directly determine
whether this murine model of MI causes significant papillary muscle
injury leading to mitral regurgitation is warranted. This is
particularly important because MR in and of itself can cause
significant LV chamber remodeling and influence local MMP/TIMP
myocardial levels (22).
Myocardial hypertrophy occurred in the TIMP-1/ mice
after MI, as evidenced by greater ventricular mass and myocyte
cross-sectional area. Because a greater degree of LV dilation occurred
in the TIMP-1/ mice, this hypertrophic response was
likely due to increased stress placed on the viable myocardium.
However, recent results have demonstrated that TIMPs may have multiple
biological effects with respect to cell growth and viability
(12). Thus the greater degree of myocardial hypertrophy in
the TIMP-1/ mice was likely multifactorial. The
increased LV volumes and hypertrophy that occurred in the
TIMP-1/ mice after MI likely gave rise to specific
changes in LV diastolic function. Specifically, LV end-diastolic
pressure was increased and myocardial active relaxation () was
prolonged in TIMP-1/ mice after MI. The mechanism for
the prolongation of isovolumic relaxation time in
TIMP-1/ mice is likely to be multifactorial. Isovolumic
relaxation can be influenced by LV loading conditions, different
degrees of hypertrophy, and abnormalities in calcium handling/reuptake.
It is likely that all of these were present in the post-MI mice.
Moreover, the degree of LV hypertrophy was greater in the
TIMP-1/ mice after MI, which would likely be manifested
as a prolongation in myocardial active relaxation. However, whether and
to what degree other processes, such as calcium handling, are affected to a more severe degree in TIMP-1/ mice remain to be examined.
The fibrillar collagen matrix forms the structural backbone of the myocardium (2). This network provides strength and stiffness to the myocardium and also contributes to the maintenance of myocyte alignment and geometry (35). Disruption of the structural collagens has been implicated in the pathophysiology of dilated cardiomyopathy. Recently, Kim and colleagues (16) demonstrated that direct disruption of the extracellular matrix in the heart by chronic myocardial overexpression of MMP-1 resulted in marked deterioration of systolic and diastolic function at 12 mo of age. TIMP-1 deficiency, which theoretically also results in increased MMP activity, has comparable cardiac effects. In the present study, LV sections were prepared for morphological assessment of the MI wound healing response as well as characterization of cellular and extracellular remodeling. Thus LV myocardial samples were not available for careful biochemical assessment of MMP levels and activational states. Four TIMP subtypes have been identified to date, which may be differentially regulated in the progression of the heart failure process (18). TIMPs may play several biological roles in tissue remodeling, including growth regulation (12). In light of the results of the present study, future research regarding the specific effects of TIMP-1 deletion on relative myocardial MMP levels and the expression of alternative TIMP proteins after the induction of MI is warranted.
In a previous study (29) we demonstrated that
TIMP-1/ mice, in the absence of an underlying
myocardial disease, had reduced content of myocardial fibrillar
collagen at 4 mo of age. In the present study, we confirmed these
results and additionally showed that these TIMP-1/
hearts, with an inadequate fibrillar collagen matrix, exhibited more
extensive LV dilatation in response to MI. Thus loss of fibrillar collagen at the starting point of our experiments (i.e., at the moment
of MI induction) may have been an important contributory factor for the
alterations in LV geometry in the TIMP-1/ mice after MI.
The egress of inflammatory cells from the vasculature, as well as the
migration of inflammatory cells through the infarcted tissue, is
dependent on a number of orchestrated steps, including the activation
of proteases. These protease systems are highly redundant, but
reduction in the activity of MMP-9 or the serine proteinase plasmin has
been shown to modify the inflammatory response after MI in mice
(5, 7, 14). The present study demonstrates that TIMP-1
deficiency does not have an apparent effect on the inflammatory
response of the heart. This may be due to the fact that at 2 wk after
MI the initial inflammatory response is largely completed or because
other TIMP molecules may have compensated for the lack of TIMP-1.
However, on the basis of the observations that fibrillar collagen was
reduced and that the length of the MI was larger in the
TIMP-1/ mice, we conclude that structural remodeling of
the MI region was altered in the absence of TIMP-1.
In the control state, ambient mean arterial pressure was higher in the
TIMP-1/ mice. The TIMP-1/ murine
construct was a global gene deletion and therefore potentially may have
influenced vascular structure and function. Specifically, alterations
in extracellular structure may have influenced vascular resistive
properties. In the present study, LV stroke volume was also slightly
higher in the control TIMP-1/ mice. Although remaining
speculative, these factors likely contributed to the differences in
arterial pressure observed in the control TIMP-1/ mice.
Future studies that directly examine vasomotor tone and vascular
structure in these TIMP-1/ mice will be necessary to
more carefully address this issue.
In conclusion, this study emphasizes the importance of local endogenous control of MMPs by TIMP-1 for the remodeling process of the heart after MI, not only with respect to extracellular matrix structure but also with respect to myocyte growth and myocardial function. Furthermore, the results from the present study emphasize the therapeutic potential for modifying post-MI architectural remodeling through local regulation of myocardial MMP activity.
| |
ACKNOWLEDGEMENTS |
|---|
This work was funded by Netherlands Heart Foundation Grant 99.054 and by National Heart, Lung, and Blood Institute Grants HL-45024, HL-97012, and PO1-HL-48788.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: F. G. Spinale, Cardiothoracic Surgery, Rm. 625, Strom Thurmond Research Bldg., 770 MUSC Complex, Medical Univ. of South Carolina, 114 Doughty St., Charleston, SC 29425.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published September 26, 2002;10.1152/ajpheart.00511.2002
Received 27 June 2002; accepted in final form 18 September 2002.
| |
REFERENCES |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1.
Baghelai, K,
Marktanner R,
Dattilo JB,
Dattilo MPM,
Jakoi ER,
Yager DR,
Makhoul RG,
and
Wechsler AS.
Decreased expression of tissue inhibitor of metalloproteinase 1 in stunned myocardium.
J Surg Res
77:
35-39,
1998[Web of Science][Medline].
2.
Caulfield, JB,
and
Borg TK.
The collagen network of the heart.
Lab Invest
40:
364-372,
1979[Web of Science][Medline].
3.
Cleutjens, JPM,
Kandala JC,
Guarda E,
Guntaka RV,
and
Weber KT.
Regulation of collagen degradation in the rat myocardium after infarction.
J Mol Cell Cardiol
27:
1281-1292,
1994.
4.
Creemers, EEJM,
Cleutjens JPM,
Smits JFM,
and
Daemen MJAP
Matrix metalloproteinase inhibition after myocardial infarction. A new approach to prevent heart failure?
Circ Res
89:
201-210,
2001
5.
Creemers, EEJM,
Cleutjens J,
Smits J,
Heymans S,
Moons L,
Collen D,
Daemen M,
and
Carmeliet P.
Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction.
Am J Pathol
156:
1865-1873,
2000
6.
Danielsen, CC,
Wiggers H,
and
Andersen HR.
Increased amounts of collagenase and gelatinase in porcine myocardium following ischemia and reperfusion.
J Mol Cell Cardiol
30:
1431-1442,
1998[Web of Science][Medline].
7.
Ducharme, A,
Frantz S,
Aikawa M,
Rabkin E,
Lindsey M,
Rohde LE,
Schoen FJ,
Kelly RA,
Werb Z,
Libby P,
and
Lee RT.
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction.
J Clin Invest
106:
55-62,
2000[Web of Science][Medline].
8.
Feldman, MD,
Mao Y,
Valvano JW,
Pearce JA,
and
Freeman GL.
Development of a multifrequency conductance catheter-based system to determine LV function in mice.
Am J Physiol Heart Circ Physiol
279:
H1411-H1420,
2000
9.
Gardin, JM,
Siri FM,
Kitsis RN,
Edwards JG,
and
Leinwand LA.
Echocardiographic assessment of left ventricular mass and systolic function in mice.
Circ Res
76:
907-914,
1995
10.
Georgakopoulos, D,
and
Kass DA.
Estimation of parallel conductance by dual-frequency conductance catheter in mice.
Am J Physiol Heart Circ Physiol
279:
H443-H450,
2000
11.
Georgakopoulos, D,
Mitzner WA,
Chen CH,
Byrne BJ,
Millar HD,
Hare JM,
and
Kass DA.
In vivo murine left ventricular pressure-volume relations by miniaturized conductance micromanometry.
Am J Physiol Heart Circ Physiol
274:
H1416-H1422,
1998
12.
Hayakawa, T,
Yamashita K,
Tanzawa K,
Uchijima E,
and
Iwata K.
Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum.
FEBS Lett
298:
29-32,
1992[Web of Science][Medline].
13.
Hayashidani, S,
Tsutsui H,
Shiomi T,
Suematsu N,
Kinugawa S,
Ide T,
Wen J,
and
Takeshita A.
Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Circulation
105:
868-873,
2002
14.
Heymans, S,
Luttun A,
Nuyens D,
Theilmeier G,
Creemers E,
Moons L,
Dyspersin GD,
Cleutjens JPM,
Shipley M,
Angellilo A,
Levi M,
Nube O,
Baker A,
Keshet E,
Lupu F,
Herbert JM,
Smits JF,
Shapiro SD,
Baes M,
Borgers M,
Collen D,
Daemen MJ,
and
Carmeliet P.
Inhibition of plasminogen activators or matrix metalloproteinases prevent cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure.
Nat Med
10:
1135-1142,
1999.
15.
Hoit, BD.
New approaches to phenotypic analysis in adult mice.
J Mol Cell Cardiol
33:
27-35,
2001[Web of Science][Medline].
16.
Kim, HE,
Dalal SS,
Young E,
Legato MJ,
Weisfeldt ML,
and
D'Armiento J.
Disruption of the myocardial extracellular matrix leads to cardiac dysfunction.
J Clin Invest
106:
857-866,
2000[Web of Science][Medline].
17.
Leenen, PJ,
de Bruijn MF,
Voerman JS,
Campbell PA,
and
van Ewijk W.
Markers of mouse macrophage development detected by monoclonal antibodies.
J Immunol Methods
174:
5-19,
1994[Web of Science][Medline].
18.
Li, YY,
Feldman AM,
Sun Y,
and
McTiernan CF.
Differential expression of tissue inhibitors of metalloproteinases in the failing human heart.
Circulation
98:
1728-1734,
1998
19.
Li, YY,
McTiernan CF,
and
Feldman AM.
Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac remodeling.
Cardiovasc Res
46:
214-224,
2000
20.
Lindsey, ML,
Gannon J,
Aikawa M,
Schoen FJ,
Rabkin E,
Lopresti-Morrow L,
Crawford J,
Black S,
Libby P,
Mitchell PG,
and
Lee RT.
Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction.
Circulation
105:
753-758,
2002
21.
Lutgens, E,
Daemen MJAP,
de Muinck ED,
and
Smits JFM
Chronic myocardial infarction in mice: structural and functional consequences.
Cardiovasc Res
41:
586-593,
1999
22.
Nagatomo, Y,
Carabello BA,
Coker ML,
McDermott PJ,
Nemoto S,
Hamawaki M,
and
Spinale FG.
Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control.
Am J Physiol Heart Circ Physiol
278:
H151-H161,
2000
23.
Nothnick, WB,
Soloway PD,
and
Curry TE, Jr.
Pattern of messenger ribonucleic acid expression of tissue inhibitors of metalloproteinases (TIMPs) during testicular maturation in male mice lacking a functional TIMP-1 gene.
Biol Reprod
59:
364-370,
1998
24.
Olivetti, G,
Capasso JM,
Sonnenblick EH,
and
Anversa P.
Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats.
Circ Res
67:
23-34,
1990
25.
Peterson, JT,
Li H,
Dillon L,
and
Bryant JW.
Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Cardiovasc Res
46:
307-315,
2000
26.
Robinson, TF,
Cohen-Gould L,
and
Factor SM.
Skeletal framework of mammalian heart muscle. Arrangement of inter- and pericellular connective tissue structures.
Lab Invest
49:
482-498,
1983[Web of Science][Medline].
27.
Rohde, LE,
Ducharme A,
Arroyo LH,
Aikawa M,
Sukhova GH,
Lopez-Anaya A,
McClure KF,
Mitchell PG,
Libby P,
and
Lee RT.
Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice.
Circulation
99:
3063-3070,
1999
28.
Ross, RS,
and
Borg TK.
Integrins and the myocardium.
Circ Res
88:
1112-1119,
2001
29.
Roten, L,
Nemoto S,
Simsic J,
Coker ML,
Rao V,
Baicu S,
Defreyte G,
Soloway PJ,
Zile MR,
and
Spinale FG.
Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice.
J Mol Cell Cardiol
32:
109-120,
2000[Web of Science][Medline].
30.
Scherrer-Crosbie, M,
Ullrich R,
Bloch KD,
Nakajima H,
Nasseri B,
Aretz HT,
Lindsey ML,
Vancon AC,
Huang PL,
Lee RT,
Zapol WM,
and
Picard MH.
Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice.
Circulation
104:
1286-1291,
2001
31.
Sivasubramanian, N,
Coker ML,
Kurrelmeyer KM,
MacLellan WR,
DeMayo FJ,
Spinale FG,
and
Mann DL.
Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor.
Circulation
104:
826-831,
2001
32.
Spinale, FG,
Coker ML,
Krombach SR,
Mukherjee R,
Hallak H,
Houck WV,
Clair MJ,
Kribbs SB,
Johnson LL,
Peterson JT,
and
Zile MR.
Matrix metalloproteinase inhibition during the development of congestive heart failure: effects on left ventricular dimensions and function.
Circ Res
85:
364-376,
1999
33.
Spinale, FG,
Coker ML,
Thomas CV,
Walker JD,
Mukherjee R,
and
Hebbar L.
Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure.
Circ Res
82:
482-495,
1998
34.
Thomas, CV,
Coker ML,
Zellner JL,
Handy JR,
Crumbley AJ,
and
Spinale FG.
Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
Circulation
97:
1708-1715,
1998
35.
Whittaker, P,
Boughner DR,
and
Kloner RA.
Role of collagen in acute myocardial infarct expansion.
Circulation
84:
2123-2134,
1991
36.
Yang, B,
Larson DF,
and
Watson R.
Age-related left ventricular function in the mouse: analysis based on in vivo pressure-volume relationships.
Am J Physiol Heart Circ Physiol
277:
H1906-H1913,
1999
This article has been cited by other articles:
|
|
 |
|
  S. K. Mani, S. Balasubramanian, J. A. Zavadzkas, L. B. Jeffords, W. T. Rivers, M. R. Zile, R. Mukherjee, F. G. Spinale, and D. Kuppuswamy Calpain inhibition preserves myocardial structure and function following myocardial infarction Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1744 - H1751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. G. Spinale, C. N. Koval, A. M. Deschamps, R. E. Stroud, and J. S. Ikonomidis Dynamic Changes in Matrix Metalloprotienase Activity Within the Human Myocardial Interstitium During Myocardial Arrest and Reperfusion Circulation, September 30, 2008; 118(14_suppl_1): S16 - S23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kelly, S. Q. Khan, M. Thompson, G. Cockerill, L. L. Ng, N. Samani, and I. B. Squire Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction Eur. Heart J., September 1, 2008; 29(17): 2116 - 2124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. McEvoy, A.-G. Taylor, J. A. Zavadzkas, I. M. Mains, R. L. Ford, R. E. Stroud, L. B. Jeffords, C. U. Beck, S. T. Reeves, and F. G. Spinale Aprotinin Exerts Differential and Dose-Dependent Effects on Myocardial Contractility, Oxidative Stress, and Cytokine Release After Ischemia-Reperfusion Ann. Thorac. Surg., August 1, 2008; 86(2): 568 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Xu, W. Wan, L. Ji, S. Lao, A. S. Powers, W. Zhao, J. M. Erikson, and J. Q. Zhang Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats Cardiovasc Res, June 1, 2008; 78(3): 523 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Frantz, S. Stork, K. Michels, M. Eigenthaler, G. Ertl, J. Bauersachs, and C.E. Angermann Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: An independent predictor of mortality Eur J Heart Fail, April 1, 2008; 10(4): 388 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J.H. Smeets, B. E.J. Teunissen, P. H.M. Willemsen, F. A. van Nieuwenhoven, A. E. Brouns, B. J.A. Janssen, J. P.M. Cleutjens, B. Staels, G. J. van der Vusse, and M. van Bilsen Cardiac hypertrophy is enhanced in PPAR{alpha}-/- mice in response to chronic pressure overload Cardiovasc Res, April 1, 2008; 78(1): 79 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. McGaffin, C.-K. Sun, J. J. Rager, L. C. Romano, B. Zou, M. A. Mathier, R. M. O'Doherty, C. F. McTiernan, and C. P. O'Donnell Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury Cardiovasc Res, January 1, 2008; 77(1): 54 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. G. Spinale Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function Physiol Rev, October 1, 2007; 87(4): 1285 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Graham and A. W. Trafford Spatial disruption and enhanced degradation of collagen with the transition from compensated ventricular hypertrophy to symptomatic congestive heart failure Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1364 - H1372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Mukherjee, J. T. Mingoia, J. A. Bruce, J. S. Austin, R. E. Stroud, G. P. Escobar, D. M. McClister Jr, C. M. Allen, M. A. Alfonso-Jaume, M. E. Fini, et al. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2216 - H2228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Alla, A. Kearney-Schwartz, A. Radauceanu, S. D. Dores, B. Dousset, and F. Zannad Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes Eur J Heart Fail, March 1, 2006; 8(2): 147 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Janssens and H. R. Lijnen What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models? Cardiovasc Res, February 15, 2006; 69(3): 585 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Vanhoutte, M. Schellings, Y. Pinto, and S. Heymans Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: A temporal and spatial window Cardiovasc Res, February 15, 2006; 69(3): 604 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lubos, R. Schnabel, H. J. Rupprecht, C. Bickel, C. M. Messow, S. Prigge, F. Cambien, L. Tiret, T. Munzel, and S. Blankenberg Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study Eur. Heart J., January 2, 2006; 27(2): 150 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Lindsey, G. P. Escobar, L. W. Dobrucki, D. K. Goshorn, S. Bouges, J. T. Mingoia, D. M. McClister Jr., H. Su, J. Gannon, C. MacGillivray, et al. Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H232 - H239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Shah Preservation of Cardiac Extracellular Matrix by Passive Myocardial Restraint: An Emerging New Therapeutic Paradigm in the Prevention of Adverse Remodeling and Progressive Heart Failure Circulation, August 30, 2005; 112(9): 1245 - 1247. [Full Text] [PDF]
|
|
|
|
|
|
M. L. Lindsey, D. K. Goshorn, C. E. Squires, G. P. Escobar, J. W. Hendrick, J. T. Mingoia, S. E. Sweterlitsch, and F. G. Spinale Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function Cardiovasc Res, May 1, 2005; 66(2): 410 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Deschamps, W. M. Yarbrough, C. E. Squires, R. A. Allen, D. M. McClister, K. B. Dowdy, J. E. McLean, J. T. Mingoia, J. A. Sample, R. Mukherjee, et al. Trafficking of the Membrane Type-1 Matrix Metalloproteinase in Ischemia and Reperfusion: Relation to Interstitial Membrane Type-1 Matrix Metalloproteinase Activity Circulation, March 8, 2005; 111(9): 1166 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Sukhova, B. Wang, P. Libby, J.-H. Pan, Y. Zhang, A. Grubb, K. Fang, H. A. Chapman, and G.-P. Shi Cystatin C Deficiency Increases Elastic Lamina Degradation and Aortic Dilatation in Apolipoprotein E-Null Mice Circ. Res., February 18, 2005; 96(3): 368 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Lovelock, A. H. Baker, F. Gao, J.-F. Dong, A. L. Bergeron, W. McPheat, N. Sivasubramanian, and D. L. Mann Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H461 - H468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Jayasankar, Y. J. Woo, L. T. Bish, T. J. Pirolli, M. F. Berry, J. Burdick, R. C. Bhalla, R. V. Sharma, T. J. Gardner, and H. L. Sweeney Inhibition of Matrix Metalloproteinase Activity by TIMP-1 Gene Transfer Effectively Treats Ischemic Cardiomyopathy Circulation, September 14, 2004; 110(11_suppl_1): II-180 - II-186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Mukherjee, A. M. Parkhurst, J. T. Mingoia, S. E. Sweterlitsch, J. S. Leiser, G. P. Escobar, F. G. Spinale, and J. P. Saul Myocardial remodeling after discrete radiofrequency injury: effects of tissue inhibitor of matrix metalloproteinase-1 gene deletion Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1242 - H1247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Wang, H. R. Brunner, and M. Burnier Determination of cardiac contractility in awake unsedated mice with a fluid-filled catheter Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H806 - H814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chen, D. Li, T. Saldeen, and J. L. Mehta TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1 Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1612 - H1617. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
P < 0.05 vs. WT-MI mice.
